More patients would be eligible for metformin use if estimated glomerular filtration rate were used to define kidney disease rather than serum creatinine, a recent study concluded.
The estimated prevalence of diabetes among U.S. adults ranged between 12% and 14% in 2011-2012, according to a recent study.
Home use of a closed-loop insulin delivery system, or artificial pancreas, appeared to be effective in patients with type 1 diabetes, according to 2 recently published reports conducted under regular living conditions.
Pioglitazone was not found to be associated with a statistically significant increased risk of bladder cancer or 8 of 10 additional cancers in a recent study.
The addition of telephone calls by health educators to printed self-management materials may improve diabetes control in low-income diabetics with worse metabolic control, a study found.
Two new studies looked at how and why statin treatment increases the risk of type 2 diabetes.
Women with type 1 diabetes may have a higher all-cause mortality risk than men with the condition, as well as higher risk for fatal and nonfatal vascular events, according to a recent study.
Among U.S. adults with diabetes, 3 in 10 are undiagnosed, possibly due to limited access to care, a study recently reported.
Tirzepatide, a not-yet-approved dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist, was tested against placebo and semaglutide in recent studies.
A study and a meta-analysis suggest incretin-based drugs don't increase the risk of pancreatitis in patients with type 2 diabetes.